Learning Objectives:

1. Define patient-reported outcomes, (PROs), and the role within oncology care.

2.  Summarize the results of secondary analysis of quality of life in indolent non-Hodgkins lymphomas.

3.  Discuss results of an investigator-initiated trial of carfilzomib-related dyspnea in Myeloma.

Session date: 
11/29/2021 - 12:00pm to 1:00pm CST
Via Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ajay Major, MD, MBA